Canadian Observation Trial in CF Patients Undergoing Treatment With Ivacaftor

Plain-language summary

This is a Canadian observational study that follows cystic fibrosis (CF) patients who are receiving Ivacaftor treatment. Any patient who is prescribed Ivacaftor may take part. It was run as an observational study with no assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Tanja Gonska

Start date

4/23/2013

Estimated completion

7/26/2017

Related genes

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* any patient being prescribed ivacaftor

Exclusion Criteria:

* only relates to specific tests